FindTrial
Sign In

Evaluation of efficacy of Dashamoola kashaya - an Ayurvedic combination of 10 drugs preparation in liquid form to do kavala - gargle in disease of throat called non specific long standing pharyngitis where there will be infection of throat for more than 3 weeks

Evaluation of Efficacy of Dashamoola kashaya Kavala in the management of chronic Non-specific Pharyngitis: An Open Labelled single arm clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015016
Enrollment
50
Registered
2018-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Non specific Pharyngitis

Interventions

Intervention1: Dashamoola Kashaya Kavala: the drug Dashamoola is a combination of 10 drugs and available in the form of churna-powder. 10gms of this powder is to be boiled in 100ml of water and reduce

Sponsors

Rajiv Gandhi University of Health sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects diagnosed with Chronic non-specific pharyngitis. 2. patients of either sex. 3.Patients aged between 10-65 yrs. 4. Hematological and biochemical parameters within normal limits. 5. Willing to sign inform consent document.

Exclusion criteria

Exclusion criteria: 1.Patients with cardiovascular, cerebrovascular, respiratory, liver or renal diseases or any other systemic disease. 2. Patients with h/o tuberculosis, leprosy, syphilis, rhinoscleroma, untreated dental caries, chronic tonsillitis, diabetes, ischemic heart disease and patients on steroid therapy. 3. Patients under antenatal and postnatal care 4. Patients unwilling to provide informed consent or abide by the requirements of the study.

Design outcomes

Primary

MeasureTime frame
Reduction in the symptoms like sore throat, cough, pain while swallowing, harshness of voice, running noseTimepoint: 60 days—

Secondary

MeasureTime frame
Reduction in recurrence Betterment of social lifeTimepoint: 60 days—

Countries

India

Contacts

Public ContactDr Sandhya Rani D

JSS Ayurveda Medical College

sandhyaranid30@yahoo.in9448584801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026